{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:11:57Z","timestamp":1795158717428,"version":"4.10.3"},"reference-count":36,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T00:00:00Z","timestamp":1205280000000},"content-version":"vor","delay-in-days":832,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Australian Dental Journal"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 2002\/2003 a number of patients presented to the South Australian Oral and Maxillofacial Surgery Unit with unusual non\u2010healing extraction wounds of the jaws. All were middle\u2010aged to elderly, medically compromised and on bisphosphonates for bone pathology. Review of the literature showed similar cases being reported in the North American oral and maxillofacial surgery literature. This paper reviews the role of bisphosphonates in the management of bone disease. There were 2.3 million prescriptions for bisphosphonates in Australia in 2003. This group of drugs is very useful in controlling bone pain and preventing pathologic fractures. However, in a small number of patients on bisphosphonates, intractable, painful, non\u2010healing exposed bone occurs following dental extractions or denture irritation. Affected patients are usually, but not always, over 55 years, medically compromised and on the potent nitrogen containing bisphosphonates, pamidronate (Aredia\/Pamisol), alendronate (Fosamax) and zolendronate (Zometa) for non\u2010osteoporotic bone disease. Currently, there is no simple, effective treatment and the painful exposed bone may persist for years. The main complications are marked weight loss from difficulty in eating and severe jaw and neck infections. Possible preventive and therapeutic strategies are presented although at this time there is no evidence of their effectiveness. Dentists must ask about bisphosphonate usage for bone disease when recording medical histories and take appropriate actions to avoid the development of this debilitating condition in their patients.<\/jats:p>","DOI":"10.1111\/j.1834-7819.2005.tb00384.x","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T10:34:11Z","timestamp":1205318051000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["The dental implications of bisphosphonates and bone disease"],"prefix":"10.1111","volume":"50","author":[{"given":"A.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mavrokokki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NL","family":"Fazzalari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DF","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A N","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,12]]},"reference":[{"key":"e_1_2_2_2_2","unstructured":"http:www.medicareaustralia.gov.au. about\/our_organisation\/annual report\/03\u201304\/statistics.htm#2. AccessedNovember 2005."},{"key":"e_1_2_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"e_1_2_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2003.09.001"},{"key":"e_1_2_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"e_1_2_2_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.99.132"},{"key":"e_1_2_2_7_2","first-page":"268","article-title":"Letter to the Editor. Bisphosphonates and avascular necrosis of the jaws","volume":"48","author":"Carter GD","year":"2003","journal-title":"Aust Dent J"},{"key":"e_1_2_2_8_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18773\/austprescr.2004.030","article-title":"Bisphosphonates and avascular necrosis of the jaws","volume":"27","author":"Carter GD","year":"2004","journal-title":"Australian Prescriber"},{"key":"e_1_2_2_9_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06761.x"},{"key":"e_1_2_2_10_2","unstructured":"http:www.fredcoutts.comzometazometanews.htmAccessedNovember 2005."},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06762.x"},{"key":"e_1_2_2_12_2","unstructured":"Expert Panel Recommendations for the prevention diagnosis and treatment of osteonecrosis of the jaws.June 2004. (Submitted for publication). Availablehttp:www.novartis.com.au."},{"key":"e_1_2_2_13_2","unstructured":"Dental Health.Taking care of yourself while living with cancer.May 2005. Availablehttp:www.novartis.com.au."},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr414"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2000.144"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008626026484"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <2961::AID-CNCR12>3.0.CO;2-L"},{"key":"e_1_2_2_18_2","first-page":"237","article-title":"Effect of pamidronate on bone blood flow in oophorectomized rats","volume":"47","author":"Kapitola J.","year":"1998","journal-title":"Physiol Res"},{"key":"e_1_2_2_19_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035295"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-2391(03)00328-8"},{"key":"e_1_2_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-003-0622-z"},{"key":"e_1_2_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.01.010"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bdj.4802906"},{"key":"e_1_2_2_24_2","first-page":"49","article-title":"The radium watch\u2010dial workers and the evolution of industrial medicine","volume":"98","author":"Sherk HH","year":"2001","journal-title":"NJ Med"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0020.2000.290608.x"},{"key":"e_1_2_2_26_2","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1210\/endo.137.6.8641182","article-title":"Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast\u2010mediated resorption","volume":"137","author":"Vitte C.","year":"1996","journal-title":"Endocrinol"},{"key":"e_1_2_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.2005.tb00390.x"},{"issue":"4","key":"e_1_2_2_28_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.47102\/annals-acadmedsg.V33N4p48S","article-title":"Bisphosphonates \u2014 a word of caution","volume":"33","author":"Robinson NA.","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_2_29_2","first-page":"111","article-title":"Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy","volume":"71","author":"Melo MD","year":"2005","journal-title":"J Can Dent Assoc"},{"key":"e_1_2_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200507073530120"},{"key":"e_1_2_2_31_2","unstructured":"http:www.fosamax\u2010lawyer.com322005. AccessedNovember 2005."},{"key":"e_1_2_2_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.2005.tb00387.x"},{"key":"e_1_2_2_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.1987.tb04155.x"},{"key":"e_1_2_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0142-9612(01)00415-X"},{"key":"e_1_2_2_35_2","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2005.76.1.107"},{"key":"e_1_2_2_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1708-8208.2003.tb00210.x"},{"key":"e_1_2_2_37_2","first-page":"74","article-title":"Failure of osseointegrated dental implants after disphosphonate therapy for osteoporosis: a case report","volume":"10","author":"Starck WJ","year":"1995","journal-title":"Int J Oral Maxillofac Implants"}],"container-title":["Australian Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1834-7819.2005.tb00384.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1834-7819.2005.tb00384.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T16:42:40Z","timestamp":1708706560000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1834-7819.2005.tb00384.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":36,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1834-7819.2005.tb00384.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1834-7819.2005.tb00384.x","archive":["Portico"],"relation":{},"ISSN":["0045-0421","1834-7819"],"issn-type":[{"value":"0045-0421","type":"print"},{"value":"1834-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"2008-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}